Home Cart Sign in  
Chemical Structure| 147511-69-1 Chemical Structure| 147511-69-1

Structure of Pitavastatin
CAS No.: 147511-69-1

Chemical Structure| 147511-69-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pitavastatin is a potent HMG-CoA reductase inhibitor and inhibits cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in a human liver cancer cell line (HepG2).

Synonyms: NK-104

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pitavastatin

CAS No. :147511-69-1
Formula : C25H24FNO4
M.W : 421.46
SMILES Code : O=C(O)C[C@H](O)C[C@H](O)/C=C/C1=C(C2=CC=C(F)C=C2)C3=CC=CC=C3N=C1C4CC4
Synonyms :
NK-104
MDL No. :MFCD04113054

Safety of Pitavastatin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H361
Precautionary Statements:P201-P202-P280-P308+P313-P405-P501

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02107898 Hypercholesterolemia Phase 3 Completed - Japan ... More >> Investigational Site Number 392016 Adachi-Ku, Japan Investigational Site Number 392029 Adachi-Ku, Japan Investigational Site Number 392024 Aki-Gun, Japan Investigational Site Number 392012 Chuo-Ku, Japan Investigational Site Number 392013 Chuo-Ku, Japan Investigational Site Number 392032 Fukui-Shi, Japan Investigational Site Number 392004 Hakusan-Shi, Japan Investigational Site Number 392028 Kaga-Shi, Japan Investigational Site Number 392002 Kanazawa-Shi, Japan Investigational Site Number 392005 Kanazawa-Shi, Japan Investigational Site Number 392023 Kawanishi-Shi, Japan Investigational Site Number 392009 Kisarazu-Shi, Japan Investigational Site Number 392026 Kitakyushu-Shi, Japan Investigational Site Number 392003 Komatsu-Shi, Japan Investigational Site Number 392011 Kuki-Shi, Japan Investigational Site Number 392017 Matsumoto-Shi, Japan Investigational Site Number 392007 Mito-Shi, Japan Investigational Site Number 392006 Moriya-Shi, Japan Investigational Site Number 392018 Nagoya-Shi, Japan Investigational Site Number 392014 Oota-Ku, Japan Investigational Site Number 392019 Osaka-Shi, Japan Investigational Site Number 392020 Osaka-Shi, Japan Investigational Site Number 392022 Osaka-Shi, Japan Investigational Site Number 392030 Osaka-Shi, Japan Investigational Site Number 392027 Oyabe-Shi, Japan Investigational Site Number 392010 Saitama-Shi, Japan Investigational Site Number 392015 Shinjuku-Ku, Japan Investigational Site Number 392031 Shizuoka-Shi, Japan Investigational Site Number 392021 Suita-Shi, Japan Investigational Site Number 392025 Takamatsu-Shi, Japan Investigational Site Number 392008 Tsuchiura-Shi, Japan Investigational Site Number 392001 Yamagata-Shi, Japan Less <<
NCT02107898 - Completed - -
NCT01502904 Stable Angina or Acute Coronar... More >>y Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension Less << Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT01890967 Hypercholesterolemia Phase 2 Completed - -
NCT01890967 - Completed - -
NCT02743260 Healthy Phase 4 Unknown December 2017 Germany ... More >> Department of Pharmacology I, University Hospital Cologne Cologne, NRW, Germany, 50931 Less <<
NCT02888327 Influenza in Humans Phase 1 Completed - United Kingdom ... More >> Hammersmith Medicines Research London, United Kingdom Less <<
NCT03418974 Dyslipidemias Phase 4 Active, not recruiting December 31, 2021 China, Beijing ... More >> Heart Center of Peking University People's Hospital Beijing, Beijing, China, 100044 China, Shanghai School of Public Health, Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT00723398 - Completed - -
NCT01265706 - Completed - Korea, Republic of ... More >> Chonnam National University Hospital Gwangju, Korea, Republic of Less <<
NCT00716846 Healthy Volunteers Not Applicable Completed - Japan ... More >> Hamamatsu University School of Medicine Hamamatsu, Japan Less <<
NCT00723398 Breast Cancer Not Applicable Completed - United States, Pennsylvania ... More >> Penn State Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT00805714 - Completed - Korea, Republic of ... More >> Cardiac and Vascular Center, Hanseo Hospital Busan, Korea, Republic of Departments of Cardiology, Catholic University of Daegu College of Medicine Daegu, Korea, Republic of Division of Cardiology, Department of Internal Medicine, School of Medicine, Keimyung University Daegu, Korea, Republic of Division of Cardiology, Heart Center, Konyang University Daejeon, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Department of Cardiovascular Medicine, Wonkwang University School of Medicine Iksan, Korea, Republic of Gachon University Gil Medical Center In Cheon, Korea, Republic of Division of Cardiology Cardiac Center, Seoul National University Bundang Hospital Seongnam, Korea, Republic of Cardiovascular Center, Korea University Guro Hospital Seoul, Korea, Republic of Heart Center, Division of Cardiology, Chung-Ang University Hospital Seoul, Korea, Republic of Less <<
NCT00548145 Alzheimer Disease ... More >> Hypercholesterolemia Less << Not Applicable Terminated - Japan ... More >> Osaka University Hospital Suita, Osaka, Japan, 565-0871 Less <<
NCT00548145 - Terminated - -
NCT01710007 Hypercholesterolemia Phase 3 Completed - Taiwan ... More >> Buddhist Taipei TzuChi General Hospital New Taipei City, Taiwan, 23142 Cardinal Tien Hospital New Taipei City, Taiwan, 231 Taipei Medical University - Shuang Ho Hospital New Taipei City, Taiwan, 23561 Taichung Veterans General Hospital Taichung City, Taiwan, 40705 Taipei Veterans General Hospital Taipei City, Taiwan, 11217 Cheng Hsin General Hospital Taipei City, Taiwan, 112 Tri-Service General Hospital Taipei City, Taiwan, 114 Chang Gung Medical Foundation- LinKuo Branch Taoyuan City, Taiwan, 333 Less <<
NCT01223586 - Completed - Japan ... More >> Division of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Yamaguchi, Japan, 755-8505 Division of Cardiology, Kyoto University Hospital Kyoto, Japan, 606-8507 Less <<
NCT01660191 - Completed - -
NCT03606824 Dyslipidemia ... More >>Subclinical hypothyro?dism Lipid-Lowering Therapy Statin Less << Not Applicable Not yet recruiting March 1, 2020 -
NCT00701285 Chronic Heart Failure Phase 4 Completed - Korea, Republic of ... More >> SEOUL St. Mary's Hospital Seoul, Seocho-Ku, Korea, Republic of, 137-040 Less <<
NCT00549926 Coronary Disease ... More >> Hypercholesterolemia Less << Phase 4 Completed - Japan ... More >> Yokohama City University Medical Center Yokohama, Japan Less <<
NCT01660191 Hypercholesterolemia Phase 4 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT02634034 Hyperlipidemia Phase 1 Completed - United States, Texas ... More >> Austin, Texas, United States, 78744 Less <<
NCT02799758 Hyperlipidemia ... More >> Dyslipidemia Less << Phase 3 Terminated November 2017 -
NCT03311841 Renal Insufficiency Phase 1 Completed - United States, Florida ... More >> Clinical Pharmacology of Miami ( Site 0001) Hialeah, Florida, United States, 33014 Orlando Clinical Research Center ( Site 0002) Orlando, Florida, United States, 32809 Less <<
NCT01178853 Healthy Phase 4 Completed - United States, Texas ... More >> Austin, Texas, United States Less <<
NCT02670434 Hyperlipidemia ... More >> Dyslipidemia Less << Phase 3 Terminated October 2017 -
NCT02344290 HIV Infections ... More >> Cardiovascular Diseases Less << Phase 3 Recruiting April 1, 2022 -
NCT00249249 - Completed - -
NCT00249249 Primary Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 3 Completed - -
NCT00242944 Coronary Disease ... More >> Hypercholesterolemia Less << Phase 4 Completed - Japan ... More >> Juntendo University School of Medicine Bunkyo-ku, Tokyo, Japan, 113-8421 Yamaguchi University Graduate School of Medicine Ube, Yamaguchi, Japan, 755-8505 Kyoto University Graduate School of Medicine Kyoto, Japan, 606-8507 Less <<
NCT01232049 Healthy Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT03070223 - Active, not recruiting February 28, 2022 -
NCT02250976 Healthy Male Volunteers Phase 1 Completed - Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, Korea, Republic of, 700-721 Less <<
NCT01178853 - Completed - -
NCT00257686 Hypercholesterolemia or Combin... More >>ed Dyslipidemia Less << Phase 3 Completed - -
NCT01767610 Healthy Male Volunteers Phase 1 Completed - Korea, Republic of ... More >> Kyungpook National University Hospital Daegu, Korea, Republic of, 700-721 Less <<
NCT00711919 Hyperlipidemia ... More >> Carotid Artery Diseases Less << Not Applicable Unknown - Japan ... More >> Ayabe City Hospital Ayabe, Kyoto, Japan, 623-0011 Fukuchiyama City Hospital Fukuchiyama, Kyoto, Japan, 620‐8505 Tanabe Central Hospital Kyotanabe, Kyoto, Japan, 610-0334 Kumihama Hospital Kyotango, Kyoto, Japan, 629-3400 Maizuru Medical Center Maizuru, Kyoto, Japan, 625-8502 Maizuru Kyosai Hospital Maizuru, Kyoto, Japan, 625-8585 Saiseikai Kyoto Hospital Nagaokakyo, Kyoto, Japan, 617-0814 Nantan General Hospital Nantan, Kyoto, Japan, 629-0197 Meiji University of Integrative Medicine Hospital Nantan, Kyoto, Japan, 629-0392 Gakken Toshi Hospital Seika, Kyoto, Japan, 619-0238 Uji Hospital Uji, Kyoto, Japan, 611-0011 Kyoto Prefectural Yosanoumi Hospital Yosano, Kyoto, Japan, 629-2261 Shiga Hospital Higashioumi, Shiga, Japan, 527-8505 Omihachiman Community Medical Center Omihachiman, Shiga, Japan, 523-0082 Saiseikai Shigaken Hospital Rittou, Shiga, Japan, 520-3046 Takeda Hospital Kyoto, Japan, 600-8558 Kyoto Prefectural University of Medicine Kyoto, Japan, 602-8566 Kyoto First Red Cross Hospital Kyoto, Japan, 605-0981 Less <<
NCT00861861 Hypercholesterolemia ... More >> Coronary Artery Disease Less << Phase 4 Completed - Japan ... More >> Kumamoto University Graduate School of Medical Sciences Department of Cardiocascular Medicine Kumamoto, Japan, 860-8556 Less <<
NCT00257686 - Completed - -
NCT02956590 Dyslipidemia ... More >>Obesity Less << Phase 3 Recruiting May 31, 2022 United States, Delaware ... More >> Nemours/Alfred I duPont Hospital for Children Not yet recruiting Wilmington, Delaware, United States, 19803 Contact: Samuel Gidding, MD       sgidding@nemours.org    Principal Investigator: Samuel Gidding, MD          United States, District of Columbia Children's National Health System Not yet recruiting Washington, District of Columbia, United States, 20010 Contact: Michele Mietus-Snyder, MD       mmsynder@childrensnational.org    Principal Investigator: Michele Mietus-Snyder, MD          United States, Georgia Emory University School of Medicine Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Miriam Voss, MD, MSPH       mvos@emory.edu    Principal Investigator: Miriam Vos, MD, MSPH          United States, Indiana Riley Hospital for Children at IU Health Not yet recruiting Indianapolis, Indiana, United States, 46202 Contact: Jacqueline Maiers, MD       jmaiers@iu.edu    Principal Investigator: Jacqueline Maiers, MD          United States, Massachusetts Boston Children's Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Sarah de Ferranti, MD, MPH       sarah.deferranti@cardio.chboston.org    Principal Investigator: Sarah de Ferranti, MD, MPH          United States, Michigan University of Michigan Health System Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Caren Goldberg, MD, MS       cgoldberg@umich.edu    Principal Investigator: Caren Goldberg, MD, MS          United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Nicolas Madsen, MD, MPH       nicolas.madsen@cchmc.org    Principal Investigator: Nicolas Madsen, MD, MPH          United States, Pennsylvania The Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Julie Brothers, MD, FAAP       brothersj@email.chop.edu    Principal Investigator: Julie Brothers, MD, FAAp          Children's Hospital of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Silva Arslanian, MD       silva.arslanian@chp.edu    Principal Investigator: Silva Arslanian, MD          United States, South Carolina Medical University of South Carolina Not yet recruiting Charleston, South Carolina, United States, 29425 Contact: Andrew Atz, MD       atzam@musc.edu    Principal Investigator: Andrew Atz, MD          United States, Texas Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: S. Kristen Sexson, MD, Phd       sxsexson@texaschildrens.org    Principal Investigator: S. Kristen Sexson, MD, Phd          United States, Utah Primary Children's Hospital, University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84108 Contact: Adam Ware, MD       adam.ware@hsc.utah.edu    Principal Investigator: Adam Ware, MD          Canada, Ontario The Hospital for Sick Children Not yet recruiting Toronto, Ontario, Canada, M5g 1X8 Contact: Brian McCrindle, MD, MPH       brian.mccrindle@sickkids.ca    Principal Investigator: Brian McCrindle, MD, MPH Less <<
NCT00344175 Hypercholesterolemia ... More >> Dyslipidemia Coronary Heart Disease Less << Phase 3 Completed - Denmark ... More >> Y Forskning, Bispebjerg Hospital Copenhagen Nv, Denmark Frederiks Hospital, Kardiologisk Frederiksberg, Denmark Kolesterollaboratoriet Hellerup, Denmark CCBR A/S Vejle, Denmark Netherlands Middellaan 5 Breda, Netherlands Bomanshof 8 Eindhoven, Netherlands Damsterdiep 9 Groningen, Netherlands Doezastraat 1 Leiden, Netherlands Kamerlingh Onnesstraat 16-18 Nijmegen, Netherlands Mathenesserlaan 247 Rotterdam, Netherlands Reigerstraat 30 Velp, Netherlands Parkdreef 142 Zoetermeer, Netherlands Spain Hospital Clinico S. Juan de Alicante San Juan, Alicante, Spain Hospital Universitario Reina Sofia Cordoba, Spain Hospital Ramon y Cajal Madrid, Spain, 28000 Fundacion Jimenez Diaz Madrid, Spain Hospital Clinico San Carlos Madrid, Spain Hospital Clinico Universitario de Santiago Santiago de Compostela, Spain Sweden Angelholms Sjukhus, Medicinkliniken Angelhom, Sweden Sahlgrenska University Hospital, Intermedicin Gothenburg, Sweden Hjartmottagningen Helsingborg, Sweden Lakarcentrum Nyponet Karineholm, Sweden Medicinkliniken Ludvika, Sweden Huslakaren i Sandviken Sandviken, Sweden Narsjukhuset Sandviken, Kardiologlab, Medicin Sandviken, Sweden Hjart & Karlcenter Sodertalje, Sweden Karolinska Universitetssjukhuset Stockholm, Sweden Hjarthuset AB Varberg, Sweden Less <<
NCT00344175 - Completed - -
NCT01166633 Hypercholesterolemia Phase 4 Completed - -
NCT00640276 Hypercholesterolemia ... More >> Metabolic Syndrome Less << Phase 4 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Bundang-gu, Gyeonggi-do, Korea, Republic of, 463-707 Hanyang Univ. Guri Hospital Guri-si, Gyeonggi-do, Korea, Republic of, 471-701 Less <<
NCT00309738 - Completed - -
NCT00309777 Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 3 Completed - -
NCT01057433 Healthy Volunteers Phase 4 Completed - United States, Texas ... More >> Austin, Texas, United States Less <<
NCT00301392 Diabetes Mellitus ... More >> Glucose Intolerance Less << Phase 4 Completed - Japan ... More >> The University of Tokyo, Graduate School of Medicine Bunkyo-ku, Tokyo, Japan, 113-8655 Less <<
NCT00786734 Percutaneous Coronary Interven... More >>tion Less << Phase 4 Withdrawn - Korea, Republic of ... More >> Catholic University of Korea Kangnam St. Mary's Hospital Seoul, Korea, Republic of Less <<
NCT01057433 - Completed - -
NCT01422369 Healthy Phase 4 Completed - United States, Texas ... More >> Austin, Texas, United States Less <<
NCT00309738 Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 3 Completed - Denmark ... More >> CCBR A/S Aalborg, Denmark CCBR A/S Ballerup, Denmark Y Forskning, Bispebjerg Hospital Copenhagen NV, Denmark Frederiks Hospital, Kardiologisk Frederiksberg, Denmark Kolesterollaboratoriet Hellerup, Denmark CCBR A/S Vejle, Denmark Netherlands Middellaan 5 Breda, Netherlands Bomanshof 8 Eindhoven, Netherlands Damsterdiep 9 Groningen, Netherlands Doezastraat 1 Leiden, Netherlands Kamerlingh Onnesstraat 16-18 Nijmegen, Netherlands Mathenesserlaan 247 Rotterdam, Netherlands Reigerstraat 30 Velp, Netherlands Parkdreef 142 Zoetermeer, Netherlands Spain Hospital Clinico S. Juan de Alicante San Juan, Alicante, Spain Hospital Clinic i Provincial Villaroel, Barcelona, Spain Hospital Universitario de Bellvitge Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital Universitario Reina Sofia Cordoba, Spain Fundacion Jimenez Diaz Madrid, Spain Hospital Clinico San Carlos Madrid, Spain Hospital Ramon y Cajal Madrid, Spain Hospital Clinico Universitario de Santiago Santiago de Compostela, Spain Hospital de Sagunto Valencia, Spain Sweden Angelholms Sjukhus, Medicinkliniken Angelhom, Sweden Sahlgrenska University Hospital, Intermedicin Gothenburg, Sweden Hjartmottagningen Helsingborg, Sweden Lakarcentrum Nyponet Karineholm, Sweden Medicinkliniken Ludvika, Sweden Hjartmottagningen Malmo, Sweden Huslakaren i Sandviken Sandviken, Sweden Narsjukhuset Sandviken, Kardiologlab, Medicin Sandviken, Sweden Hjart & Karlcenter Sodertalje, Sweden Karolinska Universitetssjukhuset Stockholm, Sweden Hjarthuset AB Varberg, Sweden Less <<
NCT00653913 Hypercholesterolemia Phase 1 Completed - -
NCT02940366 Metabolic Syndrome Phase 4 Recruiting November 30, 2019 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Hyung-Kwan Kim, MD    82-2-2072-0243    cardiman73@gmail.com    Principal Investigator: Hyung-Kwan Kim, MD Less <<
NCT00309751 Type II Diabetes Mellitus ... More >> Dyslipidemia Less << Phase 3 Completed - Denmark ... More >> CCBR Aalborg Aalborg, Denmark CCBR A/S Ballerup, Denmark CCBR Vejle Vejle, Denmark Germany Gemeinschaftspraxis am Bahnhof Berlin-Spandau, Germany Pharmakologisches Studienzentum Chemnitz Chemnitz, Germany Internistische Diabetische Schwerpunktpraxis Dr. Frankfurt Am Main, Germany Internistische Gemeinschaftspraxis Mainz, Germany Gemeinschaftspraxis Dr. Senftleber, Dr. Kohler Messkirch, Germany India Bhagwan Mahaveer Jain Heart Centre Bangalore, India Sri Ramachandra Medical College Hospital Chennai, India Apollo Hospitals Hyderabaad, India CARE Group of Hospitals Hyderabaad, India PD Hinduja Hospital Mumbai, India Netherlands Andromed Breda Breda, Netherlands Andromed Eindhoven Eindhoven, Netherlands Andromed Noord Groningen, Netherlands Andromed Leiden Leiden, Netherlands Andromed Nijmegen Nijmegen, Netherlands Andromed Rotterdam Rotterdam, Netherlands Andromed Oost Velp, Netherlands Andromed Zoetermeer Zoetermeer, Netherlands Poland Podlaski Osrodek Kardiologii Bialystok, Poland NZOZ GCP Dobra Praktyka Lekaska Gruziadz, Poland NZOZ Terapia Optima Katowice, Poland NZOZ Esculap, Przychodnia Lekary Rodzinnych Losice, Poland NZOZ Centrum, Poradnia Kardiologiczna Siedlce, Poland Spec. Gab. Lek. Internistyczno-Kardiologicznly Tarnow, Poland Woj.Szp.Spec.Nr 1 im. Prof. J. Gasinskiego Tychy, Poland Instytut Zywnosci i Zywienia Warszawa, Poland Lecznica PROSEN SMO Warszawa, Poland Szpital Wolski,im. Dr A. Gostynskiej Warszawa, Poland United Kingdom Synexus Reading Clinical Research Centre Berkshire, United Kingdom Synexus Lancashire Clinical Research Centre Lancashire, United Kingdom Synexus Merseyside Clinical Research Centre Liverpool, United Kingdom Synexus Manchester Clinical Research Centre Manchester, United Kingdom Less <<
NCT00309751 - Completed - -
NCT01422369 - Completed - -
NCT03730038 Dyslipidemias Not Applicable Not yet recruiting October 9, 2020 Korea, Republic of ... More >> Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Yangsoo Jang, MD, Ph.D    82-2-2228-8460    jangys1212@yuhs.ac Less <<
NCT01301066 Dyslipidemia Phase 4 Completed - -
NCT00444717 Metabolic Syndrome ... More >> Oxidative Stress Inflammation Less << Phase 4 Completed - Japan ... More >> Tatsuaki Matsubara Nagoya, Aichi, Japan, 464-8651 Less <<
NCT00889226 Hypercholesterolemia With Type... More >>2DM Less << Phase 4 Completed - -
NCT00309777 - Completed - -
NCT01301066 - Completed - -
NCT01043094 - Completed - -
NCT01043094 Severe Renal Impairment Phase 4 Completed - United States, Minnesota ... More >> Minneapolis, Minnesota, United States Less <<
NCT00330876 - Completed - -
NCT01648829 Coronary Artery Disease Phase 4 Unknown December 2017 Italy ... More >> Sapienza University Not yet recruiting Rome, Italy, 00166 Contact: Francesco Pelliccia, MD    +39064997 ext 123    f.pelliccia@mclink.it    Principal Investigator: Francesco Pelliccia, MD Less <<
NCT01386853 Hyperlipidemia Phase 3 Unknown July 2012 Taiwan ... More >> Changhua Christian Hospital Not yet recruiting Chang-hua, Taiwan Principal Investigator: Chien-Hsun Hsia, M.D.          Sub-Investigator: Lee-Shin Lin, M.D.          National Cheng Kung University Hospital Not yet recruiting Tainan, Taiwan Principal Investigator: Ping-Yen Liu, M.D. Ph.D.          Sub-Investigator: Po-Sheng Chen, M.D.          Sub-Investigator: Ju-Yi Chen, M.D.          Sub-Investigator: Wei-Ting Li, M.D.          Sub-Investigator: Yen-Wen Liu, M.D.          Sub-Investigator: Cheng-Han Lee, M.D.          Sub-Investigator: Wei-Chuan Tsai, M.D.          Sub-Investigator: Yi-Heng Li, M.D.          Sub-Investigator: Chih-Chan Lin, M.D.          Sub-Investigator: Shih-Hung Chan, M.D.          Sub-Investigator: Ting-Hsing Chao, M.D.          Chang Gung Memorial Hospital-LinKou Not yet recruiting Taipei, Taiwan Principal Investigator: Ming-Shien Wen, M.D. Ph.D.          Sub-Investigator: Kuo-Chun Hung, M.D.          Sub-Investigator: I-Chang Hsieh, M.D.          Sub-Investigator: Chao-Yung Wang, M.D.          Sub-Investigator: Chun-Chi Chen, M.D.          National Taiwan University Hospital Not yet recruiting Taipei, Taiwan Principal Investigator: Kuo-Liong Chien, M.D. Ph.D.          Sub-Investigator: Chia-Lun Chao, M.D.          Sub-Investigator: Ta-Chen Su, M.D. Ph.D.          Sub-Investigator: Hung-Ju Lin, M.D.          Taipei Veterans General Hospital Not yet recruiting Taipei, Taiwan Principal Investigator: Tao-Cheng Wu, M.D. Ph.D.          Sub-Investigator: Chin-Chou Huang, M.D.          Sub-Investigator: Liang-Yu Lin, M.D.          Sub-Investigator: Wen-Chung Yu, M.D.          Tri-Service General Hospital Taipei, Taiwan Less <<
NCT00330876 Hypercholesterolemia ... More >> Dyslipidemias Less << Phase 3 Completed - -
NCT01402843 Hypertension ... More >>Dyslipidemia Less << Phase 3 Completed - Korea, Republic of ... More >> Chungbuk National University Hospital Chung Ju, Korea, Republic of Konyang University Hospital Daejeon, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of Gangnam Severance Hospital Seoul, Korea, Republic of Hallym University Medical Center Seoul, Korea, Republic of Korea University Guro Hospital Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Severance Hospital Seoul, Korea, Republic of Ajou University Medical Center Suwon, Korea, Republic of Less <<
NCT00325780 - Completed - -
NCT00325780 Hypercholesterolemia ... More >> Dyslipidemia Less << Phase 3 Completed - -
NCT00344370 - Completed - -
NCT01256476 - Completed - -
NCT00344370 Type II Diabetes Mellitus ... More >> Dyslipidemia Less << Phase 3 Completed - Denmark ... More >> CCBR Aalborg Aalborg, Denmark CCBR A/S Vejle, Denmark CCBR Vejle Vejle, Denmark Germany Gemeinschaftspraxis am Bahnhof Berlin-Spandau, Germany Pharmakologisches Studienzentum Chemnitz Chemnitz, Germany Internistische Diabetische Schwerpunktpraxis Dr. Frankfurt Am Main, Germany Internistische Gemeinschaftspraxis Mainz, Germany Gemeinschaftspraxis Dr. Senftleber, Dr. Kohler Messkirch, Germany India Bhagwan Mahaveer Jain Heart Centre Bangalore, India Sri Ramachandra Medical College Hospital Chennai, India Apollo Hospitals Hyderabaad, India CARE Group of Hospitals Hyderabaad, India PD Hinduja Hospital Mumbai, India Netherlands Andromed Breda Breda, Netherlands Andromed Eindhoven Eindhoven, Netherlands Andromed Noord Groningen, Netherlands Andromed Leiden Leiden, Netherlands Andromed Nijmegen Nijmegen, Netherlands Andromed Rotterdam Rotterdam, Netherlands Andromed Oost Velp, Netherlands Andromed Zoetermeer Zoetermeer, Netherlands Poland Podlaski Osrodek Kardiologii Bialystok, Poland NZOZ GCP Dobra Praktyka Lekaska Gruziadz, Poland NZOZ Terapia Optima Katowice, Poland NZOZ Esculap, Przychodnia Lekary Rodzinnych Losice, Poland NZOZ Centrum, Poradnia Kardiologiczna Siedlce, Poland Spec. Gab. Lek. Internistyczno-Kardiologicznly Tarnow, Poland Woj.Szp.Spec.Nr 1 im. Prof. J. Gasinskiego Tychy, Poland Instytut Zywnosci i Zywienia Warszawa, Poland Lecznica PROSEN SMO Warszawa, Poland Szpital Wolski,im. Dr A. Gostynskiej Warszawa, Poland United Kingdom Synexus Reading Clinical Research Centre Berkshire, United Kingdom Synexus Lancashire Clinical Research Centre Lancashire, United Kingdom Synexus Merseyside Clinical Research Centre Liverpool, United Kingdom Synexus Manchester Clinical Research Centre Manchester, United Kingdom Less <<
NCT01422382 - Completed - -
NCT01595828 Metabolic Syndrome Phase 1 Completed - United Kingdom ... More >> Kowa Research Europe Ltd. Wokingham, United Kingdom Less <<
NCT00846118 Cardiovascular Disease Not Applicable Unknown March 2015 Japan ... More >> Division of Nephrology, Department of Internal Medicine, Juntendo Hospital Tokyo, Japan, 113-8421 Less <<
NCT01422382 Healthy Phase 4 Completed - United States, Texas ... More >> Austin, Texas, United States Less <<
NCT03532620 Prediabetic State ... More >> Hypertension Dyslipidemias Less << Phase 4 Recruiting September 2020 China, Chongqing ... More >> Fourth People's Hospital of Chongqing Recruiting Chongqing, Chongqing, China, 400014 Contact: Ruihua Yue, MD          Principal Investigator: Ruihua Yue, MD          China, Guangdong First Affiliated Hospital,Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Jun Tao, MD,PhD    +8613922191609    taojungz123@163.com    Contact: Jianning Zhang    +8615521264372    ningjenny@yeah.net    Principal Investigator: Jun Tao, MD,PhD          Second Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510260 Contact: Wenchao Qu, MD          Principal Investigator: Wenchao Qu, MD          First Affiliated Hospital of Jinan University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Jun Guo, MD          Principal Investigator: Jun Guo, MD          Shenzhen People's Hospital Not yet recruiting Shenzhen, Guangdong, China, 518020 Contact: Xin Jiang, MD          Principal Investigator: Xin Jiang, MD          People's Hospital of Zhongshan City Recruiting Zhongshan, Guangdong, China, 528403 Contact: Li Feng, MD          Principal Investigator: Li Feng, MD          China, Henan First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Heping Gu, MD          Principal Investigator: Heping Gu, MD          China, Hubei Yichang Central Hospital Recruiting Yichang, Hubei, China, 443003 Contact: Jiawang Ding, MD          Principal Investigator: Jiawang Ding, MD          China, Jiangsu Taizhou Hospital of TCM Recruiting Taizhou, Jiangsu, China, 214504 Contact: Yongguang Zhang, MD          Principal Investigator: Yongguang Zhang, MD          Wuxi People's Hospital Recruiting Wuxi, Jiangsu, China, 214023 Contact: Ruxing Wang, MD          Principal Investigator: Ruxing Wang, MD          Subei People's Hospital of Jiangsu province Not yet recruiting Yangzhou, Jiangsu, China, 225001 Contact: Shenghu He, MD          Principal Investigator: Shenghu He, MD          China, Qinghai Lanzhou University Second Hospital Recruiting Lanzhou, Qinghai, China, 730030 Contact: Feng Bai, MD          Principal Investigator: Feng Bai, MD          China, Shandong Yantaishan Hospital, Yantai Not yet recruiting Yantai, Shandong, China, 264001 Contact: Lan Zhao, MD          Principal Investigator: Lan Zhao, MD Less <<
NCT02290106 Obesity Fatty... More >> Liver, Nonalcoholic Less << Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02863185 Chronic Kidney Disease Phase 4 Recruiting December 2019 Korea, Republic of ... More >> Won Suk An Recruiting Busan, Korea, Republic of, 602-715 Contact: Won Suk An, M.D., Ph.D.    +82-51-240-2811    anws@dau.ac.kr    Dong-A University Not yet recruiting Busan, Korea, Republic of, 602715 Contact: Su Mi Lee, MD    +822405549    promise131@hanmail.net Less <<
NCT02144922 Hypertension ... More >>Cardiovascular Risk Less << Phase 4 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT01406431 Hyperlipidemia ... More >> Hypertension Less << Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT01042730 Coronary Artery Disease Not Applicable Unknown March 2017 Japan ... More >> Kyoto University Hospital Recruiting Kyoto, Japan, 606-8507 Contact: Takeshi Kimura, MD    +81-75-751-4254    taketaka@kuhp.kyoto-u.ac.jp    Juntendo University School of Medicine Recruiting Tokyo, Japan Contact: Katsumi Miyauchi, MD, PhD    +81-3-3813-3111    ktmmy@med.juntendo.ac.jp    Principal Investigator: Ryozou Nagai, MD, PhD          Principal Investigator: Masunori Matsuzaki, MD, PhD          Sub-Investigator: Hisao Ogawa, MD, PhD          Sub-Investigator: Takeshi Kimura, MD, PhD          Sub-Investigator: Hiroaki Shimokawa, MD, PhD          Sub-Investigator: Hiroyuki Daida, MD, PhD Less <<
NCT01871792 Contrast-induced Nephropathy Phase 4 Unknown February 2014 Korea, Republic of ... More >> Gachon University Gil Hospital Not yet recruiting Incheon, Korea, Republic of, 405-760 Contact: Woong Chul Kang, M.D.    +82-32-460-3663    kangwch@gilhospital.com Less <<
NCT01695954 Hyperlipidemia ... More >> HIV Less << Phase 1 Unknown October 2012 United States, New York ... More >> Bellevue/NYU AIDS Clinical Trials Unit New York, New York, United States, 10016 Less <<
NCT01764178 Hyperlipidemia ... More >> Hypertension Less << Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT02595268 Healthy Phase 1 Completed - Belgium ... More >> Antwerp, Belgium Less <<
NCT03618797 Complex-dyslipidemia Phase 3 Completed - -
NCT02056847 HbA1c Level Associated With Li... More >>pid Compositions Less << Phase 4 Completed - Korea, Republic of ... More >> JW pharmaceutical Seoul, Korea, Republic of, 137-864 Less <<
NCT03717064 Healthy Volunteers Phase 1 Active, not recruiting December 17, 2018 United States, Florida ... More >> Covance Research Unit - Daytona Daytona Beach, Florida, United States, 32117 Less <<
NCT01256476 Primary Dyslipidemia ... More >> Mixed Dyslipidemia Less << Phase 4 Completed - -
NCT02545231 Atherosclerosis ... More >> Neointima Angina Less << Phase 4 Active, not recruiting December 2017 Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Less <<
NCT02442700 HIV Dyslipide... More >>mia Less << Phase 4 Completed - -
NCT02442700 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.37mL

0.47mL

0.24mL

11.86mL

2.37mL

1.19mL

23.73mL

4.75mL

2.37mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories